EUVIMEDEUVIMED entdecken
Crossref

Afatinib in metastatic NSCLC with mutations

Matt Stenger, Jame Abraham

The Journal of Community and Supportive Oncology · 2014

DOI: 10.12788/jcso.0003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2014. Verfasst von Matt Stenger und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Stenger, M., & Abraham, J. (2014). Afatinib in metastatic NSCLC with mutations. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/jcso.0003

Vancouver

Stenger M, Abraham J. Afatinib in metastatic NSCLC with mutations. The Journal of Community and Supportive Oncology. 2014. doi:10.12788/jcso.0003

BibTeX
@article{Stenger2014,
  author = {Stenger, Matt and Abraham, Jame},
  title = {Afatinib in metastatic NSCLC with mutations},
  journal = {The Journal of Community and Supportive Oncology},
  year = {2014},
  doi = {10.12788/jcso.0003}
}
Kostenlos starten →